Regulation of Glycolysis — Revision Notes

⚡ 30-Second Revision

Key Regulatory Enzymes: — Hexokinase/Glucokinase, Phosphofructokinase-1 (PFK-1), Pyruvate Kinase.
PFK-1: — Rate-limiting step. Activated by AMP, Fructose-2,6-bisphosphate. Inhibited by ATP, Citrate, H$^+$.
Fructose-2,6-bisphosphate: — Potent PFK-1 activator. Levels controlled by bifunctional PFK-2/FBPase-2 enzyme.
Hexokinase: — Inhibited by Glucose-6-phosphate (G6P).
Glucokinase (liver/pancreas): — High $K_m$, not inhibited by G6P.
Pyruvate Kinase: — Activated by Fructose-1,6-bisphosphate (feed-forward). Inhibited by ATP, Alanine, Acetyl-CoA.
Hormonal Control (Liver):

- Insulin: Activates glycolysis (e.g., dephosphorylates PFK-2/FBPase-2 to increase F2,6BP, activates Pyruvate Kinase). - Glucagon: Inhibits glycolysis (e.g., phosphorylates PFK-2/FBPase-2 to decrease F2,6BP, inactivates Pyruvate Kinase).

2-Minute Revision

Regulation of glycolysis is crucial for matching glucose utilization to cellular energy needs and maintaining blood glucose homeostasis. The pathway is primarily controlled at three irreversible steps by allosteric enzymes: Hexokinase/Glucokinase, Phosphofructokinase-1 (PFK-1), and Pyruvate Kinase.

PFK-1 is the most significant regulatory point, acting as the rate-limiting step. It is activated by low energy signals like AMP and a powerful allosteric effector, Fructose-2,6-bisphosphate. Conversely, high energy signals such as ATP and citrate inhibit PFK-1, slowing down glucose breakdown.

Hexokinase is inhibited by its product, Glucose-6-phosphate, preventing unnecessary glucose phosphorylation. In the liver, glucokinase, a hexokinase isoform, has a lower affinity for glucose and is not product-inhibited, allowing it to respond to high blood glucose.

Pyruvate Kinase, the final regulatory enzyme, is activated by Fructose-1,6-bisphosphate (feed-forward activation) and inhibited by ATP and alanine. Hormones like insulin stimulate glycolysis, while glucagon inhibits it, especially in the liver, often through phosphorylation/dephosphorylation of these regulatory enzymes or by altering Fructose-2,6-bisphosphate levels.

5-Minute Revision

Glycolysis, the initial pathway for glucose catabolism, is under stringent regulatory control to ensure metabolic efficiency and balance. This regulation primarily targets three irreversible steps catalyzed by allosteric enzymes: Hexokinase (or Glucokinase), Phosphofructokinase-1 (PFK-1), and Pyruvate Kinase.

1. Hexokinase/Glucokinase (Step 1):

Hexokinase (most tissues): — High affinity for glucose, inhibited by its product, Glucose-6-phosphate (G6P). This prevents glucose trapping if downstream pathways are saturated.
Glucokinase (liver, pancreatic $\beta$-cells): — Low affinity for glucose (high $K_m$), not inhibited by G6P. This allows the liver to process large amounts of glucose after a meal and enables $\beta$-cells to sense high blood glucose.

2. Phosphofructokinase-1 (PFK-1) (Step 3): This is the rate-limiting and most important regulatory step.

Inhibitors: — High ATP (signals abundant energy), high Citrate (signals ample precursors from TCA cycle), low pH (prevents lactic acidosis).
Activators: — High AMP (signals low energy), Fructose-2,6-bisphosphate (F2,6BP).
F2,6BP: — A potent allosteric activator. Its levels are controlled by the bifunctional enzyme PFK-2/FBPase-2. Insulin promotes F2,6BP synthesis (activating PFK-2 domain), while glucagon promotes its degradation (activating FBPase-2 domain).

3. Pyruvate Kinase (PK) (Step 10):

Inhibitors: — High ATP, Alanine (synthesized from pyruvate), Acetyl-CoA (in liver, from fatty acid oxidation).
Activators: — Fructose-1,6-bisphosphate (feed-forward activation, ensuring flux through later steps if earlier steps are active).
Covalent Modification (Liver PK): — Glucagon-mediated phosphorylation inactivates liver PK, inhibiting glycolysis. Insulin dephosphorylates and activates it.

Hormonal Control:

Insulin: — Released post-meal, promotes glucose utilization. Activates glycolysis by increasing F2,6BP levels (via PFK-2) and activating Pyruvate Kinase.
Glucagon: — Released during fasting, promotes glucose conservation. Inhibits glycolysis by decreasing F2,6BP levels (via FBPase-2) and inactivating Pyruvate Kinase.

Understanding these interconnected regulatory points is key to grasping how the body maintains metabolic balance.

Prelims Revision Notes

Glycolysis regulation is critical for NEET. Remember the three primary regulatory enzymes: Hexokinase/Glucokinase, PFK-1, and Pyruvate Kinase. PFK-1 is the rate-limiting step. Its activity is crucial.

It is activated by AMP (low energy) and Fructose-2,6-bisphosphate (F2,6BP). F2,6BP is the most potent activator. PFK-1 is inhibited by ATP (high energy) and Citrate (abundant precursors). Hexokinase is inhibited by its product, Glucose-6-phosphate (G6P).

Glucokinase, found in the liver and pancreas, has a high $K_m$ (low affinity for glucose) and is *not* inhibited by G6P, allowing it to process high glucose loads. Pyruvate Kinase is activated by Fructose-1,6-bisphosphate (feed-forward activation) and inhibited by ATP, Alanine, and Acetyl-CoA.

Hormonal control is significant, especially in the liver. Insulin generally promotes glycolysis by increasing F2,6BP (activating PFK-2) and activating Pyruvate Kinase (dephosphorylation). Glucagon inhibits glycolysis by decreasing F2,6BP (activating FBPase-2) and inactivating Pyruvate Kinase (phosphorylation).

Be able to differentiate between feed-forward activation (e.g., Fructose-1,6-bisphosphate activating Pyruvate Kinase) and feedback inhibition (e.g., ATP inhibiting PFK-1). Also, understand the tissue-specific differences, particularly between liver and muscle, in terms of hexokinase isoforms and hormonal responsiveness.

Questions often test these specific activators, inhibitors, and hormonal effects in various physiological contexts.

Vyyuha Quick Recall

To remember PFK-1 activators and inhibitors: Powerful Factors Keeping 1st step regulated: Activators: AMP, Fructose-2,6-Bisphosphate (A-F2,6BP) Inhibitors: ATP, Citrate, Hydrogen ions (A-C-H)